Learn more

CELLTREND GMBH

Overview
  • Total Patents
    51
  • GoodIP Patent Rank
    51,132
  • Filing trend
    ⇩ 100.0%
About

CELLTREND GMBH has a total of 51 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2001. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets measurement, biotechnology and pharmaceuticals are SYNCERUS S A R L, ANSH LABS LLC and ARQUER DIAGNOSTICS LTD.

Patent filings per year

Chart showing CELLTREND GMBHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Heidecke Harald 50
#2 Schulze-Forster Kai 44
#3 Mertens Peter 4
#4 Scheibenbogen Carmen 3
#5 Luft Thomas 2
#6 Mueller Dominik 1
#7 Dechend Ralf 1
#8 Wallukat Gerd 1
#9 Dragun Duska 1

Latest patents

Publication Filing date Title
WO2021028468A1 Diagnosis of cancer using detection of antibodies directed against pd1 and pd-l1
WO2017207616A1 Diagnosis of cancer by detecting auto-antibodies against y box binding protein (yb-1)
WO2017140794A1 Anti-cxc chemokine receptor antibodies and c-x-c chemokines for the diagnosis of autoimmune disease and graft-versus-host disease
EP3373799A1 Prognosis of adverse outcomes by determination of midkine levels after cardiovascular stress
WO2016188979A1 DIAGNOSIS OF CHRONIC FATIGUE DISEASES USING DETECTION ANTIBODIES DIRECTED AGAINST A β- ADRENERGIC RECEPTOR
US2018284117A1 Method for diagnosing APS using determination of anti-PAR1 antibodies
EP3213075A1 Diagnosis of an autoimmune disease using detection of antibodies directed against c5a-receptor
WO2016005369A1 Par2 antibodies for diagnosis of graft intolerance of a liver transplant
EP3102945A1 Diagnosis of cancer by detecting auto-antibodies against epidermal growth factor (egf)
US2017176444A1 Diagnosis of cancer by detecting auto-antibodies against vascular endothelial growth factor receptor (VEGFR)
WO2015117956A1 Diagnosis of cancer by detecting auto-antibodies against par1
US2017010271A1 Diagnosis of cancer by detecting auto-antibodies against EGF-receptor
EP3102946A1 Diagnosis of cancer by detecting auto-antibodies against vascular endothelial growth factor (vegf)
AU2011311765A1 A new method for diagnosing hypertension as well as cardiomyopathies
CA2796003A1 Method for diagnosis of multiple sclerosis involving anti-at1-receptor antibody
WO2011015381A1 Method for prognosis of pulmonary arterial hypertension by detecting anti-par1-antibodies
WO2011015380A1 Method for prognosis of pulmonary arterial hypertension by detecting anti-par2-antibodies
EP2015075A1 Method for the prediction of the likelihood of a major adverse coronary event (MACE) in a patient with acute coronary syndromes (ACS)
EP1884775A1 Method for diagnosis of a disease involving an anti-AT1-receptor antibody
EP1884776A1 Method for diagnosis of a disease involving an anti-endothelin-receptor antibody